Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 12651 - 12675 of 15144 in total

L-Xylopyranose

Experimental

1-Deoxy-Ribofuranose-5'-Phosphate

Experimental

D-erythrose 4-phosphate

Experimental

N-acetyl-D-glucosamine-6-phosphate

Experimental

N,O6-Disulfo-Glucosamine

Experimental

Tyvelose

Experimental

(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-oxo-3-piperidinyl beta-D-glucopyranoside

Experimental

beta-D-arabinofuranose 5-phosphate

Experimental

2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose

Experimental

5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione

Experimental

Heptulose-2-Phosphate

Experimental

4-hydroxybenzoic acid

Experimental

beta-(1->4)-galactotriose

Experimental

Dipicolinic acid

Experimental

3,4-Dihydro-2'-deoxyuridine-5'-monophosphate

Experimental

2-Deoxy-alpha-D-galactopyranose

Experimental

Thiodigalactoside

Thiodigalactoside is a solid. This compound belongs to the dihexoses. These are disaccharides containing two hexose carbohydrates. This medication is known to target galectin-1, heat-labile enterotoxin b chain, neurocan core protein, and lactose permease.
Experimental
Matched Description: … This medication is known to target galectin-1, heat-labile enterotoxin b chain, neurocan core protein, and …

Alpha-D-Glucose-1-Phosphate-6-Vanadate

Experimental

3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid

Experimental

2-deoxy-2-fluoro-β-D-mannose

Experimental

Acedoben

Experimental

4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE

Experimental

H TYPE II TRISACCHARIDE

Experimental

Lividomycin A

Experimental

Renzapride

Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
Displaying drugs 12651 - 12675 of 15144 in total